[1]Pravin M, Debabrata B, Adit B. Chemokines at the crossroads of tumor-broblast interactions that promote malignancy[J]. J Leuk Biol, 2011, 89(1): 31-39.
[2]Pages F, Berger A, Camus M, et al. Effector memory T cells early metastasis, and  survival in colorectal cancer[J]. N Engl J Med, 2005, 353(25): 2654-2666.
[3]Galon J, Costes A, Sanehez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome[J]. Science, 2006, 313(5795): 1960-1964.
[4]Orimo A, Weinberg RA. Stromal fibroblasts in cancer: a novel tumor-promoting cell type[J]. Cell Cycle, 2006, 5(15): 1597-1601.
[5]Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis[J]. Cell, 2006, 124(2): 263-266.
[6]Dirkx AE, Egbrink O, Wagstaf FJ, et al. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis[J]. J Leukoc Biol, 2006, 80(6): 1183-1196.
[7]Lamagna C, Aurrandlions M, Imhof BA. Dual role of macrophages in tumor growth and angiogenesis[J]. J Leukoc Biol, 2006, 80(4): 705-713.
[8]Schoppmarn SF, Fenzl A, Nagy K, et al. VEGF-C expressing tumor-associated macrophages in lymphnode positive breast cancer: impact on lymph angiogenesis and survival[J]. Surgery, 2006, 139(6): 839-846.
[9]Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments[J]. Cancer Res, 2006, 66(2): 605-612.
[10]Khosravi-Shahi P, Soria-Lovelle A, Perez-Manga G. Tumoral angiogenesis and breast cancer[J]. Clin Transl Oncol, 2009, 11(3): 138-142.
[11]Bian XW, Wang QL, Xiao HL, et al. Tumor microvascular architecture phenotype(T-MAP) as a new concept for studies of angiogenesis and oncology[J]. J Neurooncol, 2006, 80(2): 211-213.
[12]Bian XW, Jiang XF, Chen JH, et al. Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas[J]. Int Immunopharmacol, 2006, 6(1): 90-99.
[13]Khosravi-Shahi P, Soria-Lovelle A, Perez-Manga GT. Umoral angiogenesis and breast cancer[J]. Clin Transl Oncol, 2009, 11(3): 138-142.
[14]Folberg R, Arbieva Z, Moses J, et al. Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns[J]. Am Pathol, 2006, 169(4): 1376-1389.
[15]朱芳，李振宇，任精华，等. VEGF与肿瘤血管生成拟态关系的研究[J]. 临床肿瘤学杂志，2009，14（1）：20-24.
[16]李英华，杨丽眷. 乳腺癌的超声声像图表现与病理组织学的联系[J]. 医学影像学杂志，2008，18（4）：449-450.
[17]杨力，钱隽，赵宝珍. 乳腺恶性肿瘤126例超声图像与病理对照研究[J]. 第二军医大学学报，2003，24（8）：s6-s7.
[18]卞和星. 乳腺癌的高频超声表现与于术后病理对照分析[J]. 中国血液流变学杂志，2006，16（4）：688-689.
[19]Kim HC, Yang DM, Nam DH, et al. Ultrasound-guided biopsy of focal lesions using three-dimensional ultrasound with a matrix array transducer comparison with 2-dimensional ultrasound in a phantom study[J]. Invest Radiol, 2011, 46(4): 264-270.
[20]朱庆莉，姜玉新，孙强，等. 乳腺癌彩色多普勒血流显像的多因素分析[J]. 中华超声影像学杂志，2006，15（2）：109-112.
[21]Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound(CEUS) in the liver update 2012: a WFUMB EFSUMB initiative in cooperation with representatives of FSUMB, AIUM, ASUM, FLAUS and ICUS[J]. Ultraschall Med, 2013, 34(1): 11-29.
[22]张文芳，王志刚. 超声造影在乳腺癌诊断和治疗中的研究进展[J]. 临床超声医学杂志，2008，10（6）：399-401.
[23]Wan CF, Du J, Fang H, et al. Enhancement patterns and parameters of breast cancers at contrast-enhanced US: correlation with prognostic factors[J]. Radiology, 2012, 262(2): 450-459.
[24]李振洲，罗长锐，方凡，等. 乳腺癌超声造影定性及定量分析与p53表达的相关性研究[J]. 中国临床医学影像杂志，2012，23（7）：465-467；487.
[25]郑元义，王志刚，冉海涛，等. 自制高分子材料超声造影剂及初步实验研究[J]. 中国超声医学杂志，2004，20（12）：887-890.
[26]Bzyl J, Lederle W, Rix A, et al. Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents(BR55 and BR38)[J]. Eur Radiol, 2011, 21(9): 1988-1995.
[27]朱庆莉，游珊珊，孝梦甦，等. 对比超声定位光散射断层成像与彩色多普勒血流显像检测乳腺癌血供[J]. 中国医学影像技术，2011，27（9）：1833-1837.
[28]Schnitt SJ. Molecular biology of breast tumor progression: a view from the other side[J]. Int J Surg Pathol, 2010, 18(3 suppl): 170S-173S.
[29]Sahebali S, Vanden Eynden G, Murta EF, et al. Stromal issues in cervical cancer: a review of the role and function of basement membrane, stroma, immune response and angiogenesis in cervical cancer development[J]. Eur J Cancer Prev, 2010, 19(3): 204-215.